Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 2048-2052

  Yoshida, Tomoaki ^a   Fukada, Masako ^b   Koide, Naoki ^b   Ikeda, Hiroshi ^b   Sugiyama, Tsuyoshi ^b   Kato, Yutaka ^b   Ishikawa, Naohisa ^b   Yokochi, Takashi ^b  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; SHIGA TOXIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

APOPTOSIS; BACTERIAL TOXINS; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXIMIDE; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; HUMANS; PROTEIN SYNTHESIS INHIBITORS; SAPHENOUS VEIN; SHIGA TOXINS; UMBILICAL ARTERIES; UMBILICAL VEINS;

EID: 0032735978     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315116     Document Type: Article

References (15)

1. 1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lier H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151:775-82.
2. 2. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8.
3. 3. Louise CB, Obrig TG. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 1995;172:1397-1401.
4. 4. Kondo F, Kobayashi S, Matsumoto K, et al. Analysis of Vero toxins 1 and 2 by high-performance liquid chromatography/electrospray ionization mass spectrometry. Journal of Mass Spectrometry 1997;32:1140-2.
5. 5. van de Kar NC, Kooistra T, Vermeer M, Lesslauer W, Monnens LA, van Hinsbergh VW. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood 1995;85:734-43.
6. 6. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vivo. Infect Immun 1993;61:3886-91.
7. 7. Araki S, Ishida T, Yamamoto T, Kaji K, Hayashi H. Induction of apoptosis by hemorrhagic snake venom in vascular endothelial cells. Biochem Biophys Res Commun 1993;190:148-53.
8. 8. Mangeney M, Lingwood CA, Taga S, et al. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 1993; 53:5314-9.
9. 9. Kiyokawa N, Taguchi T, Mori T, et al. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis 1998;178:178-84.
10. 10. Inward CD, Williams J, Chant I, et al. Verocytotoxin-1induces apoptosis in vero cells. J Infect 1995;30:213-8.
11. 11. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997;89:2429-42.
12. 12. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988;171:45-50.
13. 13. Van Setten PA, van Hinsbergh VW, Van den Heuvel LP, et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 1997;8:1877-88.
14. 14. Ashikaga T, Strada SJ, Thompson WJ. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells. Biochem Pharmacol 1997;54:1071-9.
15. 15. van Setten PA, van Hinsbergh VW, van der Velden TJ, et al. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997;51:1245-56.